These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1282758)

  • 1. Antibodies to hepatitis C virus in Cuban blood donors.
    Rivero RA; Hedalgo-Gato R; Martinez M; Hernandez P; Ballester JM; Yamaguchi K; Fukuyoshi Y; Kiyokawa T; Takatsuki K
    Vox Sang; 1992; 63(4):285-6. PubMed ID: 1282758
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):335-8. PubMed ID: 2177594
    [No Abstract]   [Full Text] [Related]  

  • 3. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of anti-HCV and ALT in blood donors].
    Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C
    Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 6. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels.
    Rumi MG; Colombo M; Gringeri A; Mannucci PM
    Ann Intern Med; 1990 Mar; 112(5):379-80. PubMed ID: 2106281
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-HVC antibodies and recipients of blood products: preliminary results of a prospective survey performed at a Parisian C. H. U].
    Lunel F; Azar N; Fournel JJ; Valla D; Foucault C; Habibi B; Jaulmes D; Perrin M; Opolon P; Huraux JM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):361-7. PubMed ID: 2177600
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-HCV antibodies among blood donors in Cantabria. Incidence and relation to transaminase levels].
    Pastor JM; Hermosa V; Ruiz Tagle MA; Zubizarreta A
    Sangre (Barc); 1990 Jun; 35(3):205-7. PubMed ID: 2118687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C antibody and transaminase activities in blood donors.
    Morgan C; Hyland C; Young IF
    Lancet; 1990 Apr; 335(8694):921. PubMed ID: 1970011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Post-transfusion non-A, non-B hepatitis: towards risk zero].
    de Andrade Júnior DR; de Andrade DR
    Arq Gastroenterol; 1992; 29(1):1-4. PubMed ID: 1284884
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection of antibodies against the hepatitis C virus in Cuban blood donors].
    Rivero RA; Yamaguchi K; Hidalgo-Gato R; Martínez M; Hernández P; Ballester JM
    Sangre (Barc); 1992 Aug; 37(4):301. PubMed ID: 1325074
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
    Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
    Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
    [No Abstract]   [Full Text] [Related]  

  • 14. Infectivity of blood seropositive for hepatitis C virus antibodies.
    van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN
    Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to hepatitis C virus in French blood donors.
    Janot C; Couroucé AM; Maniez M
    Lancet; 1989 Sep; 2(8666):796-7. PubMed ID: 2571026
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-hepatitis C antibodies in prospectively followed-up transfused patients.
    Couroucé AM; Jullien AM; Vedrenne JB; Habibi B
    Vox Sang; 1990; 58(3):226-7. PubMed ID: 2111065
    [No Abstract]   [Full Text] [Related]  

  • 17. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.
    van der Poel CL; Reesink HW; Lelie PN; Leentvaar-Kuypers A; Choo QL; Kuo G; Houghton M
    Lancet; 1989 Aug; 2(8658):297-8. PubMed ID: 2569103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to hepatitis C virus in Italian blood donors.
    Sirchia G; Bellobuono A; Giovanetti A; Marconi M
    Lancet; 1989 Sep; 2(8666):797. PubMed ID: 2571027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.